Astellas Pharma (Thailand) Co. Ltd Education Grant Application
Release Date: February 18, 2021
I. Background
Astellas Pharma (Thailand) Co. Ltd is committed to supporting high quality,
evidence-based medical education that seeks to improve the overall safety and
quality of patient care and treatment. The intent of this Call for Grant Applications (CGA) is to encourage organizations to submit grant applications for education meetings, focusing on the programs designed to close knowledge gaps identified in the public healthcare landscape, drive measurable improvements in knowledge, competence and performance of healthcare professionals, and advance patient health outcomes. The qualified program must be independent, i.e., the projects funded by the companies are the full responsibility of the recipient organization. The Companies do not have influence over any aspect of the supported projects and only ask for interim and final outcomes reports including a description of the impact of the projects.
All applications must be submitted online through the Astellas Thailand to the noncommercial function lead, [email protected] or Ethics & Compliance lead, [email protected]
II. Eligibility
Geographic Scope: |
Thailand Only |
Applicant |
Eligible applicants include hospitals, academic and medical schools, (Note: the CME Office must submit the request for accredited activities); and national-level professional medical associations/societies.
|
III. Requirements
Date CGA Issued |
December 11, 2020 |
Application Deadline |
March 15, 2021 |
Anticipated Grant |
March 31, 2021 |
Clinical Area |
Oncology , Urology, Transplantation, Rheumatology |
Specific Education Gaps |
The purpose of this CGA is to encourage Organizations to submit grant applications for independent education designed to enhance understanding of increasingly complex treatment options and close knowledge gaps in the provided clinical area. |
How to Submit |
All interested applicants may request to receive copy of application from noncommercial function lead, [email protected] or Ethics & Compliance lead, [email protected] and return application to same lead. |
Target Audiences |
Urologists, medical oncologists, nephrologists, urogynecologists, rheumatologist, and other HCPs responsible for treatment decisions for patients having disease related to Astellas Thailand’s therapeutic area.
|
Expected amount of Grant Applications |
Registration for virtual meeting for 10 HCPs per HCO. |
IV. Terms and Conditions
1. This CGA does not commit the Companies or their partners to award a grant or a grant of
any particular amount if one is awarded, nor to pay any costs incurred in the preparation
of a response to this request.
2. The Companies reserve the right to accept or reject any or all applications received as a
result of this request, or to cancel this CGA in part or in its entirety at any time for any
reason.
3. All communications about the CGA must be sent to Astellas Thailand to [email protected] or Ethics & Compliance lead, [email protected] Applicants should not contact other departments
within Astellas regarding this CGA. Failure to comply may affect the acceptance of your
application.
4. The decision by the Companies to provide a grant will not be determined in a manner
that takes into account the volume or value of any business otherwise generated
between Astellas and any applicant.
--------------------------------